Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L P Schacter

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Seminars in Oncology|December 1, 1992
Drug discovery and development in the pharmaceutical industryL P Schacter, C Anderson, R M Canetta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1995
Phase II randomized study of cisplatin plus etoposide phosphate or etoposide in the treatment of small-cell lung cancerJ D Hainsworth, N Levitan, G L Wampler, et al.
Investigational New Drugs|January 1, 1996
Phase II study of elsamitrucin (BMY-28090) for the treatment of patients with refractory/relapsed non-Hodgkin's lymphomaS L Allen, L P Schacter, S M Lichtman, et al.
Blood|December 15, 1992
Effects of therapy with didanosine on hematologic parameters in patients with advanced human immunodeficiency virus diseaseL P Schacter, M Rozencweig, M Beltangady, et al.
Clinical Pharmacology and Therapeutics|May 1, 1995
A phase I study of etoposide phosphate administered as a daily 30-minute infusion for 5 daysD S Thompson, A Greco, A A Miller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1995
Phase I study of etoposide phosphate (etopophos) as a 30-minute infusion on days 1, 3, and 5S Z Fields, L N Igwemezie, S Kaul, et al.
Bone Marrow Transplantation|November 1, 1996
Phase I study of high-dose etoposide phosphate in manS Z Fields, D R Budman, R R Young, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1992
Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: a phase III trial of the Southeastern Cancer Study GroupB J Roth, D H Johnson, L H Einhorn, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Seminars in Oncology|December 1, 1992
Drug discovery and development in the pharmaceutical industryL P Schacter, C Anderson, R M Canetta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1995
Phase II randomized study of cisplatin plus etoposide phosphate or etoposide in the treatment of small-cell lung cancerJ D Hainsworth, N Levitan, G L Wampler, et al.
Investigational New Drugs|January 1, 1996
Phase II study of elsamitrucin (BMY-28090) for the treatment of patients with refractory/relapsed non-Hodgkin's lymphomaS L Allen, L P Schacter, S M Lichtman, et al.
Blood|December 15, 1992
Effects of therapy with didanosine on hematologic parameters in patients with advanced human immunodeficiency virus diseaseL P Schacter, M Rozencweig, M Beltangady, et al.
Clinical Pharmacology and Therapeutics|May 1, 1995
A phase I study of etoposide phosphate administered as a daily 30-minute infusion for 5 daysD S Thompson, A Greco, A A Miller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1995
Phase I study of etoposide phosphate (etopophos) as a 30-minute infusion on days 1, 3, and 5S Z Fields, L N Igwemezie, S Kaul, et al.
Bone Marrow Transplantation|November 1, 1996
Phase I study of high-dose etoposide phosphate in manS Z Fields, D R Budman, R R Young, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1992
Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: a phase III trial of the Southeastern Cancer Study GroupB J Roth, D H Johnson, L H Einhorn, et al.
Pageof 3